Legionnaires' disease.
D000284:Administration, Oral; D004917:Erythromycin / Q000627:therapeutic use*; D005455:Fluorescent Antibody Technique; D006801:Humans; D007877:Legionnaires' Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D012293:Rifampin / Q000627:therapeutic use*; D013183:Sputum / Q000276:immunology
D004917:Erythromycin; D012293:Rifampin